Literature DB >> 1096790

Antidiabetic drugs after the University Group Diabetes Program (UGDP).

J H Karam, S B Matin, P H Forsham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096790     DOI: 10.1146/annurev.pa.15.040175.002031

Source DB:  PubMed          Journal:  Annu Rev Pharmacol        ISSN: 0066-4251            Impact factor:   13.820


× No keyword cloud information.
  6 in total

Review 1.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 2.  The Mechanism of Action of Biguanides: New Answers to a Complex Question.

Authors:  Laura Di Magno; Fiorella Di Pastena; Rosa Bordone; Sonia Coni; Gianluca Canettieri
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  Metformin-associated lactic acidosis in Sweden 1977-1991.

Authors:  B E Wiholm; M Myrhed
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.

Authors:  S E Fineberg; S H Schneider
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

Review 5.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 6.  A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Authors:  Mozhgan Dorkhan; Anders Frid
Journal:  Vasc Health Risk Manag       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.